JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $136,900 | +66.7% | 74,000 | 0.0% | 0.00% | – |
| Q4 2022 | $82,140 | -48.0% | 74,000 | +9.5% | 0.00% | – |
| Q3 2022 | $158,000 | -19.8% | 67,600 | +3.8% | 0.00% | – |
| Q2 2022 | $197,000 | -53.3% | 65,100 | +4.8% | 0.00% | – |
| Q1 2022 | $422,000 | -18.4% | 62,100 | +0.3% | 0.00% | – |
| Q4 2021 | $517,000 | +12.4% | 61,900 | 0.0% | 0.00% | – |
| Q3 2021 | $460,000 | +9.3% | 61,900 | 0.0% | 0.00% | – |
| Q2 2021 | $421,000 | -26.7% | 61,900 | +10.7% | 0.00% | – |
| Q1 2021 | $574,000 | +46.8% | 55,900 | 0.0% | 0.00% | – |
| Q4 2020 | $391,000 | -14.3% | 55,900 | 0.0% | 0.00% | – |
| Q3 2020 | $456,000 | +16.9% | 55,900 | -1.1% | 0.00% | – |
| Q2 2020 | $390,000 | +63.9% | 56,500 | +12.5% | 0.00% | – |
| Q1 2020 | $238,000 | -35.3% | 50,200 | +19.2% | 0.00% | – |
| Q4 2019 | $368,000 | +162.9% | 42,100 | 0.0% | 0.00% | – |
| Q3 2019 | $140,000 | -32.7% | 42,100 | 0.0% | 0.00% | – |
| Q2 2019 | $208,000 | -18.8% | 42,100 | +1.9% | 0.00% | – |
| Q1 2019 | $256,000 | +84.2% | 41,300 | 0.0% | 0.00% | – |
| Q4 2018 | $139,000 | -48.1% | 41,300 | 0.0% | 0.00% | – |
| Q3 2018 | $268,000 | -11.8% | 41,300 | +4.0% | 0.00% | – |
| Q2 2018 | $304,000 | -23.6% | 39,700 | +123.0% | 0.00% | – |
| Q1 2018 | $398,000 | +130.1% | 17,800 | +30.9% | 0.00% | – |
| Q4 2017 | $173,000 | -11.7% | 13,600 | +7.9% | 0.00% | – |
| Q3 2017 | $196,000 | +10.7% | 12,600 | 0.0% | 0.00% | – |
| Q2 2017 | $177,000 | – | 12,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 4,447,829 | $30,245,000 | 89.29% |
| TRV GP III, LLC | 3,048,780 | $20,732,000 | 3.62% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,644 | $1,704,000 | 0.76% |
| PFM Health Sciences, LP | 3,262,833 | $22,187,000 | 0.70% |
| Yorktown Management & Research Co Inc | 56,600 | $385,000 | 0.30% |
| Sofinnova Investments, Inc. | 624,756 | $4,248,000 | 0.24% |
| Omega Fund Management, LLC | 275,513 | $1,873,000 | 0.21% |
| PATHWAY CAPITAL MANAGEMENT, LP | 60,279 | $410,000 | 0.16% |
| Orbimed Advisors | 2,147,400 | $14,602,000 | 0.15% |
| Grace Capital | 18,669 | $127,000 | 0.08% |